Science Journal of Clinical Medicine

| Peer-Reviewed |

Prevalence of Hyperuricemia (HU) in Arterial Hypertension

Received: 29 May 2015    Accepted: 15 June 2015    Published: 04 July 2015
Views:       Downloads:

Share This Article

Abstract

Introduction: Hyperuricemia constitutes a risk for many organs and its prevalence is high ranging from 15-20% up to 35% in developing countries. HU relation to arterial hypertension was pointed out in the end of the XIX century and is recognized as independent cardiovascular risk factor. Thus HU is less studied in our environment which justifies our work to determine prevalence and with HU associated factors among hypertensive patients followed in the Cardiology department in the Mother Child Hospital “Le Luxembourg”. Methodology: It’s was a cross-sectional study in the Mother-Child Hospital “Le Luxembourg” in Bamako. All patients with complete labor tests were included making a sample of 51 hypertensive outpatients seen from July 2010 to January 2011. For any included patient, socio-demographic and biological variables were collected. In the same way a chest radiography, an ECG and an echocardiography were realized. Patients were asked about their knowledge about HU Hyperuricemia was defined as an uricemia > 420 μmol/l for men and 360 μmol/l for women. Microsoft Excel 2007 was used to gather data and SPSS version 12 to perform analyzes. Results: Mean age of the sample was 56,35 years, the sex-ratio Male: Female 0,76. Hyperuricemia, hypercreatininemia and hyperglycemia were found respectively in 66,7,33,3% and 23,5% of the cases. 78,4% of the patients had stated to have heard about hyperuricemia, 27,5% knew their hyperuricemia. The socio-demographic characteristics did not present a statistically significant difference. Conclusion: Hyperuricemia as a cardiovascular risk factor, had to be researched and managed more agressively. The very high proportion of patients with a hyperuricemia requires to detect it among hypertensive patients, to carry out an early treatment and thus to reduce the cardiovascular risk of the patient.

DOI 10.11648/j.sjcm.20150404.12
Published in Science Journal of Clinical Medicine (Volume 4, Issue 4, July 2015)
Page(s) 76-79
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Hypertension, Hyperuricemia, Cardiology, Bamako

References
[1] Scorr JT. Asymptomatic hyperuricaemia. British Medical Journal (Clinical research ed). 1987;294(6578):987-988.
[2] Snaith ML. Gout, Hyperuricaemia, And Crystal Arthritis BMJ : British Medical Journal. 1995;310(6978):521-524.
[3] Slot O. Hyperuricemia (Abstract). Ugeskr Laeger. 1994 ;156(16):2396-401.
[4] Feig DI, Kang DH, Johnson RJ., Uric acid and cardiovascular risk. N Engl J Med 2008; 359:1811-21.
[5] Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and Risk of Stroke: A Systematic Review and Meta-analysis. Arthritis Rheum. 2009 July 15; 61(7): 885–892 doi:10.1002/art.24612
[6] Krishnan E. Hyperuricemia and incident heart failure. Circ Heart Fail. 2009 November ; 2(6): 556–562.
[7] Hurtes X, Meria P. Atteintes uro-néphrologiques des hyperuricémie. Presse Med (2011), doi:10.1016/j.lpm.2011.05.006
[8] Mijiyawa M, Bouglouga OE. Hyperuricémie et goutte en zone intertropicale. Revue du rhumatisme 2003 (70):152-156
[9] Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F and Burnier M. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004, 4:9.
[10] Hadjeres S, Saudan P. L’Hyper uricémie dans l’hypertension artérielle et l’insuffisance rénale : facteur causal ou épiphénomène? Revue médicale Suisse, numéro : 3192 : 1- 6. Visité mai 2011. www.medhyg.ch/formation/article.php3? sid=33881
[11] HØieggen et al: Serum uric acid in the LIFE study. Kidney International 2004; 65: 1041-49
[12] Culleton BF, Larson MG, Kannel WB, Levy D., Serum uric acid and risk for cardiovascular disease and death:The Framingham heart study. Ann Intern Med 1999; 131:7-13.
[13] Allard A, Bardin T. Hyperuricémie et risque cardiovasculaire (abstract ). L'actualité rhumatologique 2009. http://www.em-consulte.com/article/278000/hyperuricemie-et-risque-cardiovasculaire. Doi : 10.1016/B978-2-8101-0150-4.00011-4
[14] Mene P, Punzo G. Uric acid: Bystander or culprit in hypertension and progressive renal disease? (abstract). J Hypertension 2008; 26: 2085 – 92
[15] Deléaval P, Burnier M. L’hyperuricémie dans l’hypertension artérielle: quelle implication? Revue Médicale Suisse 2005; 32. http://www.revmed.ch/rms/2005/RMS-32/30649. Accessed on 22.04.15
[16] Chen et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B 2007; 8(8):593-598
[17] Sui X, Church TS, Meriwether RA, Lobelo F and Blair SN. Uric Acid and the Development of Metabolic Syndrome in Women and Men. Metabolism. 2008;57(6): 845–852.
Author Information
  • University Hospital ?Gabriel Touré?, Cardiology, Bamako, Mali

  • University Hospital ?Le Luxembourg ?, Cardiology, Bamako, Mali

  • National support center for the fight against the disease, Bamako, Mali

  • University Hospital ?Point G?, Cardiology, Bamako, Mali

  • University Hospital ?Point G?, Cardiology, Bamako, Mali

  • National support center for the fight against the disease, Bamako, Mali

  • National support center for the fight against the disease, Bamako, Mali

  • University Hospital ?Gabriel Touré?, Cardiology, Bamako, Mali

  • University Hospital ?Gabriel Touré?, Cardiology, Bamako, Mali

  • University Hospital ?Yalgado Ouedraogo?, Cardiology, Ouagadougou, Burkina, Faso

  • University Hospital ?Gabriel Touré?, Cardiology, Bamako, Mali

  • University Hospital ?Point G?, Cardiology, Bamako, Mali

  • National support center for the fight against the disease, Bamako, Mali

Cite This Article
  • APA Style

    Bâ Hamidou Oumar, Menta Ichaka, Maiga Asmaou Kéita, Daou Adama, Diall Ilo Bella, et al. (2015). Prevalence of Hyperuricemia (HU) in Arterial Hypertension. Science Journal of Clinical Medicine, 4(4), 76-79. https://doi.org/10.11648/j.sjcm.20150404.12

    Copy | Download

    ACS Style

    Bâ Hamidou Oumar; Menta Ichaka; Maiga Asmaou Kéita; Daou Adama; Diall Ilo Bella, et al. Prevalence of Hyperuricemia (HU) in Arterial Hypertension. Sci. J. Clin. Med. 2015, 4(4), 76-79. doi: 10.11648/j.sjcm.20150404.12

    Copy | Download

    AMA Style

    Bâ Hamidou Oumar, Menta Ichaka, Maiga Asmaou Kéita, Daou Adama, Diall Ilo Bella, et al. Prevalence of Hyperuricemia (HU) in Arterial Hypertension. Sci J Clin Med. 2015;4(4):76-79. doi: 10.11648/j.sjcm.20150404.12

    Copy | Download

  • @article{10.11648/j.sjcm.20150404.12,
      author = {Bâ Hamidou Oumar and Menta Ichaka and Maiga Asmaou Kéita and Daou Adama and Diall Ilo Bella and Coulibaly Souleymane and Doumbia Coumba Thiam and Daffé Sanoussi and Sidibé Noumou and Sangaré Ibrahima and Millogo Georges Rosario Christian and Touré Mamadou and Sidibé Salimata and Diarra Mamadou Bocary},
      title = {Prevalence of Hyperuricemia (HU) in Arterial Hypertension},
      journal = {Science Journal of Clinical Medicine},
      volume = {4},
      number = {4},
      pages = {76-79},
      doi = {10.11648/j.sjcm.20150404.12},
      url = {https://doi.org/10.11648/j.sjcm.20150404.12},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.sjcm.20150404.12},
      abstract = {Introduction: Hyperuricemia constitutes a risk for many organs and its prevalence is high ranging from 15-20% up to 35% in developing countries. HU relation to arterial hypertension was pointed out in the end of the XIX century and is recognized as independent cardiovascular risk factor. Thus HU is less studied in our environment which justifies our work to determine prevalence and with HU associated factors among hypertensive patients followed in the Cardiology department in the Mother Child Hospital “Le Luxembourg”. Methodology: It’s was a cross-sectional study in the Mother-Child Hospital “Le Luxembourg” in Bamako. All patients with complete labor tests were included making a sample of 51 hypertensive outpatients seen from July 2010 to January 2011. For any included patient, socio-demographic and biological variables were collected. In the same way a chest radiography, an ECG and an echocardiography were realized. Patients were asked about their knowledge about HU Hyperuricemia was defined as an uricemia > 420 μmol/l for men and 360 μmol/l for women. Microsoft Excel 2007 was used to gather data and SPSS version 12 to perform analyzes. Results: Mean age of the sample was 56,35 years, the sex-ratio Male: Female 0,76. Hyperuricemia, hypercreatininemia and hyperglycemia were found respectively in 66,7,33,3% and 23,5% of the cases. 78,4% of the patients had stated to have heard about hyperuricemia, 27,5% knew their hyperuricemia. The socio-demographic characteristics did not present a statistically significant difference. Conclusion: Hyperuricemia as a cardiovascular risk factor, had to be researched and managed more agressively. The very high proportion of patients with a hyperuricemia requires to detect it among hypertensive patients, to carry out an early treatment and thus to reduce the cardiovascular risk of the patient.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Prevalence of Hyperuricemia (HU) in Arterial Hypertension
    AU  - Bâ Hamidou Oumar
    AU  - Menta Ichaka
    AU  - Maiga Asmaou Kéita
    AU  - Daou Adama
    AU  - Diall Ilo Bella
    AU  - Coulibaly Souleymane
    AU  - Doumbia Coumba Thiam
    AU  - Daffé Sanoussi
    AU  - Sidibé Noumou
    AU  - Sangaré Ibrahima
    AU  - Millogo Georges Rosario Christian
    AU  - Touré Mamadou
    AU  - Sidibé Salimata
    AU  - Diarra Mamadou Bocary
    Y1  - 2015/07/04
    PY  - 2015
    N1  - https://doi.org/10.11648/j.sjcm.20150404.12
    DO  - 10.11648/j.sjcm.20150404.12
    T2  - Science Journal of Clinical Medicine
    JF  - Science Journal of Clinical Medicine
    JO  - Science Journal of Clinical Medicine
    SP  - 76
    EP  - 79
    PB  - Science Publishing Group
    SN  - 2327-2732
    UR  - https://doi.org/10.11648/j.sjcm.20150404.12
    AB  - Introduction: Hyperuricemia constitutes a risk for many organs and its prevalence is high ranging from 15-20% up to 35% in developing countries. HU relation to arterial hypertension was pointed out in the end of the XIX century and is recognized as independent cardiovascular risk factor. Thus HU is less studied in our environment which justifies our work to determine prevalence and with HU associated factors among hypertensive patients followed in the Cardiology department in the Mother Child Hospital “Le Luxembourg”. Methodology: It’s was a cross-sectional study in the Mother-Child Hospital “Le Luxembourg” in Bamako. All patients with complete labor tests were included making a sample of 51 hypertensive outpatients seen from July 2010 to January 2011. For any included patient, socio-demographic and biological variables were collected. In the same way a chest radiography, an ECG and an echocardiography were realized. Patients were asked about their knowledge about HU Hyperuricemia was defined as an uricemia > 420 μmol/l for men and 360 μmol/l for women. Microsoft Excel 2007 was used to gather data and SPSS version 12 to perform analyzes. Results: Mean age of the sample was 56,35 years, the sex-ratio Male: Female 0,76. Hyperuricemia, hypercreatininemia and hyperglycemia were found respectively in 66,7,33,3% and 23,5% of the cases. 78,4% of the patients had stated to have heard about hyperuricemia, 27,5% knew their hyperuricemia. The socio-demographic characteristics did not present a statistically significant difference. Conclusion: Hyperuricemia as a cardiovascular risk factor, had to be researched and managed more agressively. The very high proportion of patients with a hyperuricemia requires to detect it among hypertensive patients, to carry out an early treatment and thus to reduce the cardiovascular risk of the patient.
    VL  - 4
    IS  - 4
    ER  - 

    Copy | Download

  • Sections